Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors
about
Transient transmission of porcine endogenous retrovirus to fetal lambs after pig islet tissue xenotransplantation.Pig endogenous retroviruses and xenotransplantation.Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.Xenotransplantation-associated infectious risk: a WHO consultation.Infectious risk in xenotransplantation--what post-transplant screening for the human recipient?First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 5: recipient monitoring and response plan for preventing diseasIdentification and expression analysis of human endogenous retrovirus Y (HERV-Y) in various human tissues.Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases.Molecular and enzymatic characterization of the porcine endogenous retrovirus protease.Can Antiretroviral Drugs Be Used to Treat Porcine Endogenous Retrovirus (PERV) Infection after Xenotransplantation?Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.AN69 hollow fiber membrane will reduce but not abolish the risk of transmission of porcine endogenous retroviruses.Porcine endogenous retroviruses PERV-A and PERV-B infect neither mouse cells in vitro nor SCID mice in vivo.Differential sensitivity of porcine endogenous retrovirus to APOBEC3-mediated inhibition.Xenotropic murine leukemia virus-related virus is susceptible to AZT.Lamivudine resistance in human T-cell leukemia virus type 1 may be due to a polymorphism at codon 118 (V-->I) of the reverse transcriptase.Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control.Long-term effects of PERV-specific RNA interference in transgenic pigs.PERVading strategies and infectious risk for clinical xenotransplantation
P2860
Q33390100-F1970D39-7FFF-46AC-8E6B-FE634CAACFA9Q34680921-3E40B0F5-4A3C-4EB7-82FB-15CCEE303C81Q35940563-FEDC453F-AF6F-44F2-9E9B-838B3EBAAB04Q36917438-C7F218F2-16DE-45E2-945B-23336E1598D9Q37158889-5DBDD76F-9BDA-4371-A83D-BE9B92E8FC76Q37893202-C94AE4F6-4AD9-422A-9627-B3C0CD21AF36Q38751243-A8CD21AE-D336-459A-A463-632BF551C94BQ38994199-530D27A6-4EA7-4423-A5EC-4F236C639EACQ39595254-356ABAA6-43DB-4817-8003-039BD566921FQ39684356-D2F749B2-F97A-4425-92AD-2A8E85634E9DQ40090982-28A2589C-FC5D-424C-8392-68E773B3270AQ40138976-7B9B2B77-C52F-4424-8D5E-6A8CA808B8D9Q40321687-89C70047-B158-4F6D-B1BC-8657B953515BQ40438545-43DB38E9-AFB0-4AD8-904B-3CAB8290BF3FQ40898035-7E30521D-F618-4825-B68E-75CB837C25C9Q41879645-501C784F-1A8B-44C8-97FB-0754716F2E8AQ42700019-F2DBA917-81CE-4792-98CF-ED242DA43CCBQ43216472-7FE4190F-19B9-4A6F-9AD9-B6045D33A19CQ50499168-1FF44083-BB63-41D2-95C4-955585C7559FQ58766476-B5030D75-186C-4982-9291-241E849C6C2A
P2860
Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Susceptibility of the porcine ...... iptase and protease inhibitors
@ast
Susceptibility of the porcine ...... iptase and protease inhibitors
@en
type
label
Susceptibility of the porcine ...... iptase and protease inhibitors
@ast
Susceptibility of the porcine ...... iptase and protease inhibitors
@en
prefLabel
Susceptibility of the porcine ...... iptase and protease inhibitors
@ast
Susceptibility of the porcine ...... iptase and protease inhibitors
@en
P2093
P2860
P1433
P1476
Susceptibility of the porcine ...... iptase and protease inhibitors
@en
P2093
A I Hussain
C Patience
J G García-Lerma
Y Takeuchi
P2860
P304
P356
10.1128/JVI.75.2.1048-1053.2001
P577
2001-01-01T00:00:00Z